DON in Pediatric Cerebral Malaria, a Phase I/IIA Dose-Escalation Safety Study: Study Protocol for a Clinical Trial
TRIALS(2024)
Key words
6-Diazo-5-oxo-L-norleucine,DON,Glutamine antagonist,Cerebral malaria,Malaria,Plasmodium falciparum,Africa
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined